Medtronic to scale up H’bad R&D unit to global enterprise excellence centre

Medtronic to scale up  H’bad R&D unit to global  enterprise excellence centre

Medical technology leader Medtronic is significantly scaling up its research and development centre— Medtronic Engineering & Innovation Centre (MEIC)— in Hyderabad to the ranks of a global enterprise centre of excellence. The Indian facility, which will see a fresh investment of Rs 1200 crore over the next five years, will thus become the second largest R&D hub globally for Medtronic after the US, in terms of innovation capabilities and contribution. MEIC-Hyderabad is currently engaged in advanced engineering research and product development in the areas of design, analysis, advanced hardware-software development. 

Announcing the India R&D investment plan, Medtronic’s executive chairman Omar Ishrak had said in August that the expansion of the Hyderabad centre will help serve the Medtronic Mission to use medical technology to alleviate pain, restore health and extend life for patients around the world, which is also aligned with the government of India’s vision to improve access to healthcare for patients in the country. 

Madan Krishnan, Vice President, Indian Subcontinent and Minimally Invasive Therapies Group APAC, said; “At Medtronic, invention and innovation are vital so that we can help enhance therapy outcomes for people with chronic diseases. In this context, the Hyderabad MEIC, which was accorded the highest honour of ‘Star of Excellence’ in Medtronic this year, has been a classic example of a centre that is continuously proving its quality and efficiency and adding value to the group’s technology capabilites.” 

“In the medical devices industry, unlike many other industries, a significant part of the value is in the R&D and the quality and regulatory aspects, before you release the product. In research and development, whether it is breakthrough or incremental, innovation is key. That’s why we felt that India is delivering the best as a source of talented and quality people and this centre has also started delivering at global standards. So, it was an obvious choice to invest more here and make this centre one of the global hubs,” said Krishnan in an interview with Future Medicine. 

Of course, he added, the futuristic vision of Government of Telangana and access to great infrastructure enabled his company to make the investment in Hyderabad. “I’m confident that this major investment would create many job opportunities in healthcare and help energise the medical devices innovation ecosystem in India,” he said. The Government of Telangana and Medtronic have been in discussion for the last two years regarding the modalities of this investment plan. During his visit to the United States in 2016, the state’s minister for Industries & IT, KT Rama Rao and his team of officials had a meeting with the Medtronic chairman. 

Thanks to the Hyderabad centre, which was set up in 2011, and another R&D facility in Bangalore, Medtronic already has a large presence in engineering research and development in India. These engineering R&D centres have a team strength of more than 350 engineers now, supporting global teams with product design and development capabilities to serve international markets. “With the expansion, the centre would grow in headcount and partner with Global Business Units on new product development & released product engineering in embedded and enterprise software space in various therapy groups of Medtronic. The MEIC talent is also supporting R & D efforts in RF generators, robotic assisted surgery, navigation, ventilators and in cardiovascular devices and software etc. ” said Cdr. Divya Prakash Joshi, Senior Engineering Director & Site Leader, MEIC Hyderabad.